Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-38.31	-4.81	7.79
Graham Fair Price	-38.48	2.75	4.46
PEG	-1.32	-0.07	0.07
Price/Book	32.15	2.14	1.62
Price/Cash Flow	-68.93	1.01	3.24
Prices/Earnings	106.01	9.96	-4.84
Price/Sales	-53.01	0.29	0.62
Price/FCF	-68.93	1.01	3.24
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	39.83	0.05	-0.04
ROA	-51.68	< 0.005	< 0.005
ROE	-0.08	0.05	-35.85
ROIC	-0.03	0.05	93.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.12	-0.02	550.39
Dividends QOQ	0.04	< 0.005	-91.28
EBIT QOQ	0.33	4.02	1116.86
EPS QOQ	0.71	1.48	108.75
FCF QOQ	5.98	2.27	-62.07
Revenue QOQ	3.96	1.16	-70.73
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.55	0.64	15.60
Quick Ratio	113.33	0.08	-99.93
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	3.25	2.50	-23.19
Cash	11.34	10.00	-11.88
Capex	0.00	0.00	0.00
Free Cash Flow	1.62	5.30	226.66
Revenue	8.46	18.28	116.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	80.55	0.15	-99.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-26.16	5.14	-80.35
Naive Interpretation	Member

06 - Financial Health · Bad

Rating